From: Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
LSRII | LSRII (nodules all < 20 mm) | Navios | |
---|---|---|---|
Total samples | 150 | 132 | 32 |
Cancer | 28 | 13 | 6 |
Non-cancer | 122 | 119 | 26 |
Sensitivity (95% CI) | 0.82 (0.64–0.92) | 0.92 (0.67–0.99) | 0.83 (0.44–0.97) |
Specificity (95% CI) | 0.88 (0.81–0.92) | 0.87 (0.80–0.92) | 0.77 (0.58–0.89) |
Accuracy (95% CI) | 0.87(0.80–0.91) | 0.88 (0.81–0.92) | 0.78 (0.61–0.89) |
Area under ROC curve (95% CI) | 0.89 (0.83–0.96) | 0.94 (0.89–0.99) | 0.85 (0.71–0.98) |
Positive predictive value (95% CI) | |||
Cancer prevalence in data set | 0.61 (0.48–0.72) | 0.44 (0.33–0.57) | 0.45 (0.27–0.65) |
Prevalence reported in high-riska | 0.05 (0.03–0.09) | 0.06 (0.04–0.92) | 0.03 (0.01–0.06) |
Prevalence in LDCT positiveb | 0.17 (0.11–0.25) | 0.18 (0.12–0.26) | 0.10 (0.05–0.19) |
Negative predictive value (95% CI) | |||
Cancer prevalence in data set | 0.96 (0.91–0.98) | 0.99 (0.94–1.00) | 0.95 (0.77–0.99) |
Prevalence reported in high-riska | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) |
Prevalence in LDCT positiveb | 0.99 (0.99–1.00) | 1.00 (0.98–1.00) | 0.99 (0.96–1.00) |
Positive diagnostic likelihood ratio (PDLR)c | 6.31 | 7.08 | 3.61 |